In addition to targeting CD276 and the SMAD-mediated EMT process as reported in their studies, we further identified SPRY1—which has been reported to induce EMT in CRC [24]—as a novel target gene of miR-187-3p. Here, SPRY1 is linked to colorectal carcinoma.